 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 06/27/2022 |
$0.59 |
$0.60 |
$0.56 |
$0.59 |
654.90K | | 06/28/2022 |
$0.58 |
$0.59 |
$0.54 |
$0.55 |
398.00K | | 06/29/2022 |
$0.54 |
$0.56 |
$0.51 |
$0.52 |
621.00K | | 06/30/2022 |
$0.53 |
$0.54 |
$0.50 |
$0.51 |
354.60K | | 07/01/2022 |
$0.51 |
$0.53 |
$0.50 |
$0.51 |
248.20K |
|
|
| Aeglea BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biotechnology company developing human enzyme therapeutics for people with rare metabolic diseases. Co.'s development programs include: Pegzilarginase in Arginase 1 Deficiency, which is a recombinant human Arginase 1 that enzymatically degrades the amino acid arginine and improves the stability and arginine-degrading activity of the enzyme in human plasma; and AGLE-177 in Homocystinuria, which is a PEGylated, or polyethylene glycol modified, human enzyme engineered to degrade free homocysteine and homocystine. Co.'s preclinical pipeline includes cystinuria program to reduce plasma cystine and cysteine levels. | |
|
Aeglea BioTherapeutics (AGLE) has the following price history information. Looking back at AGLE historical stock prices for the last five trading days, on June 27, 2022, AGLE opened at $0.59, traded as high as $0.60 and as low as $0.56, and closed at $0.59. Trading volume was a total of 654.90K shares. On June 28, 2022, AGLE opened at $0.58, traded as high as $0.59 and as low as $0.54, and closed at $0.55. Trading volume was a total of 398.00K shares. On June 29, 2022, AGLE opened at $0.54, traded as high as $0.56 and as low as $0.51, and closed at $0.52. Trading volume was a total of 621.00K shares. On June 30, 2022, AGLE opened at $0.53, traded as high as $0.54 and as low as $0.50, and closed at $0.51. Trading volume was a total of 354.60K shares. On July 01, 2022, AGLE opened at $0.51, traded as high as $0.53 and as low as $0.50, and closed at $0.51. Trading volume was a total of 248.20K shares.
AGLE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aeglea BioTherapeutics shares, starting with a $10,000 purchase of AGLE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/08/2016 |
|
| End date: |
07/01/2022 |
|
| Start price/share: |
$11.99 |
|
| End price/share: |
$0.51 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-95.75% |
|
| Average Annual Total Return: |
-39.74% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$425.55 |
|
| Years: |
6.23 |
|
|
|
| Date |
Close |
| 06/27/2022 | $0.59 | | 06/28/2022 | $0.55 | | 06/29/2022 | $0.52 | | 06/30/2022 | $0.51 | | 07/01/2022 | $0.51 |
|
|
Free AGLE Email Alerts:
